Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.

Inclusion Criteria

• •Male or female, age 18 years or older at the time of signing informed consent
• •History of at least one self-reported unsuccessful dietary effort to lose body weight
• •For subjects without T2D at screening:
• •Body mass index (BMI) of :
• •greater than or equal to 30 kg/m\^2
• •greater than or equal to 27 kg/m\^2 with the presence of at least one of the following weight-related comorbidities (treated or untreated): hypertension, dyslipidaemia, obstructive sleep apnoea or cardiovascular disease
• •For subjects with T2D at screening:
• •Diagnosed with T2D above or equal to 180 days prior to the day of screening
• •Treated with either:
• •diet and exercise alone or
• •stable treatment (same drug(s), dose and dosing frequency) for at least 60 days prior to the day of screening with up to 3 oral antidiabetic medications alone or in any combination (metformin, α-glucosidase inhibitor (AGI), SU, glinides, SGLT2i or glitazone) according to local label
• •HbA1c 7.0-10.0% (53-86 mmol/mol) (both inclusive)
• •BMI greater than or equal to 27 kg/m\^2